Tradestie Institutional Equity Comparison Engine
HOLX vs LH โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
HOLX Overall Edge
HOLX Captures Institutional Edge (2โ2 Pillars ยท 5โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Hologic Inc (HOLX) driven by superior Growth & Margin, Options & Structure while LH counters with relative strength in Valuation, Momentum & Technical. Fundamentally, HOLX trades at 20.1x Forward P/E with 23.0% operating margin (+2.5% YoY revenue) versus LH at 18.7x Forward P/E and 11.2% operating margin (+6.9% YoY). In options structure, HOLX sits in UNCLASSIFIED (3rd %ile IV; Dealer Gamma Walls on Pro) against LH sits in CONSOLIDATION (44th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
LH
HOLX 20.1x vs LH 18.7x Fwd P/E
Growth & Margin Winner
HOLX
Op Margin 23.0% vs 11.2% ยท YoY +2.5% vs +6.9%
Momentum & Technical Winner
LH
1Y +25.5% vs +40.9% ยท 52W Pos 100% vs 94%
Options & Structure Winner
HOLX
UNCLASSIFIED (3rd %ile IV) vs CONSOLIDATION (44th %ile IV)
HOLX
NASDAQ
Hologic Inc
X-Ray Apparatus & Tubes & Related Irradiation Apparatus
$76.01
+0.48% 1D
Market Cap
$16.9B
1M Return
+0.34%
1Y Return
+25.51%
Forward P/E
20.1x
Unified AI Score
64.2 / 100
BUY
Tech 75.0
Fund 61.0
Flow 54.0
Mom 49.2
LH
NYSE
Labcorp Holdings Inc.
Services-Medical Laboratories
$367.13
-0.47% 1D
Market Cap
$30.0B
1M Return
+11.28%
1Y Return
+40.91%
Forward P/E
18.7x
Unified AI Score
44.1 / 100
HOLD
Tech 25.0
Fund 35.0
Flow 51.0
Mom 31.1
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
HOLX +25.51%
LH +40.91%
Spread: +2.86 pp (LH Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
HOLX TTM Op. Margin: 23.0%
LH TTM Op. Margin: 11.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HOLX vs LH. Trailing 12-month operating profitability (HOLX 23.0% vs LH 11.2%) and valuation multiples (HOLX 20.1x vs LH 18.7x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | HOLX | LH | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $16.9B | $30.0B | Larger Scale | LH |
| Trailing P/E Ratio Valuation | 31.4x | 30.2x | Lower Multiple | LH |
| Forward P/E Ratio Valuation | 20.1x | 18.7x | Lower Multiple | LH |
| Revenue Growth (YoY) Growth | +2.5% | +6.9% | Higher Growth | LH |
| Operating Margin (TTM) Profitability | 23.0% | 11.2% | Higher Margin | HOLX |
| Net Profit Margin Profitability | 13.2% | 6.9% | Higher Margin | HOLX |
| Return on Equity (ROE) Capital Efficiency | 10.9% | 11.4% | Higher ROE | LH |
| 52-Week Range Position Momentum | 100% ($52โ$76) | 94% ($245โ$375) | Stronger Trend | HOLX |
| Beta / 30D Volatility Risk Regime | 0.08ฮฒ ยท 3% Vol | 0.33ฮฒ ยท 35% Vol | Lower Realized Risk | HOLX |
| Unified Institutional Score Composite Signal | 64.2 / 100 (BUY) | 44.1 / 100 (HOLD) | Higher Composite | HOLX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full HOLX vs LH Buy Guide
HOLX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
3rd %ile
IV Regime
Compressed (<25th %ile)
LH
CONSOLIDATION
63d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
44th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither HOLX nor LH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.